Tourmaline Bio
TRML
TRML
51 hedge funds and large institutions have $457M invested in Tourmaline Bio in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 48 → 51 (+3)
0.97% more ownership
Funds ownership: 6.26% → 7.22% (+0.97%)
Holders
51
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10.1M | |
| 2 | +$9.73M | |
| 3 | +$4.17M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.3M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.14M |
Top Sellers
| 1 | -$8.46M | |
| 2 | -$2.74M | |
| 3 | -$1.04M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$870K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$664K |